Stock Events

Stock Events

Search...

Sangamo Therapeutics (SGMO) Q1 2025 Earnings

17MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.27

-0.17

-0.06

0.04

Details

Expected EPS

-0.09125

Actual EPS

-0.11

Surprise EPS

-0.02

Surprise Percent

+20.55%

Description

Sangamo Therapeutics (SGMO) has reported earnings of -0.11 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.